Clinical Trial: Bed-line study on amniotic fluid transcriptome sequencing technology to improve the effectiveness of prenatal diagnosis of birth defects (China)

Posted On: 2026-08-11

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Bed-line study on amniotic fluid transcriptome sequencing technology to improve the effectiveness of prenatal diagnosis of birth defects'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129437

Registration Time: 2026/08/04

Type: Observational study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336415

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Bed-line study on amniotic fluid transcriptome sequencing technology to improve the effectiveness of prenatal diagnosis of birth defects (China)